Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Adicionar filtros

Base de dados
Tipo de documento
Tipo de estudo
Aspecto clínico
Ano de publicação
Intervalo de ano
BioLaw Journal ; 2021(SpecialIssue 2):17-33, 2021.
Artigo em Inglês | Scopus | ID: covidwho-1341974


Group vulnerability is a standard issue in bioethics. Research ethics guidelines highlight the need for protection of vulnerable participants, and clinical trials are ruled by ethical and legal principles that concern possible health inequities experienced by vulnerable populations. In both the literature and the regulation, two conceptions of vulnerability are at work. On the one hand, the inherent vulnerability that is part of the human condition;on the other hand, the situational vulnerability that is associated with specific contextual factors, and that point out either a reduced autonomy or a greater risk of harms for individuals belonging to some groups. Both these two conceptions of vulnerability are exacerbated during a pandemic;on the one hand, specific populations are at heightened risk for medical complications from the virus (elderly, or immunodepressed);on the other hand, specific groups experience an increased vulnerability due to the social determinants of health, which influence individual resilience and exacerbate the impact of the virus. Among the many (income distribution, education and literacy, working condition, house and living conditions, disability, access to health services, etc.) the dramatic reduction of the space for free and informed consent, because of the mental and physical adverse effects coming from social isolation, age, culture, literacy, is relevant for both clinical research and practice. In this paper, I will discuss challenges for the informed consent in the context of the Covid-19 pandemic, with specific consideration of the condition of vulnerable groups. © 2021

Actualidad Juridica Iberoamericana ; - (12):96-107, 2020.
Artigo em Espanhol | Scopus | ID: covidwho-896426


This article discusses the current policies to face the Coronavirus SARS-CoV-2 (COVID-19) pandemic, in a bioethical perspective. In particular, through the analysis of declarations and statements issued by the most important international institutions in the bioethical field, I analyse the principles that are considered relevant in global health emergencies, as well as for public health challenges. In the second part, the risks of the policies adopted by some European countries are highlighted, as well as their economic and social ramifications such as quarantine and re-allocation of resources, with specific consideration of the condition of most vulnerable people. © 2020 Ibero-American Law Institute. All rights reserved.